Ingelheim, Germany, 3rd September, 2012 – New phase II data presented for the first time today at the 2012 European Respiratory Society (ERS) congress show that combining tiotropium with olodaterol ...
A major breakthrough to change the lives of cystic fibrosis sufferers. The trial looked at the treatment of patients with two copies of the F508DEL mutation which is carried by roughly half of all ...
Percutaneous and laparoscopic-assisted cryoablation of small renal cell carcinomas. Background: Combination of certain immunotherapies with TKI’s has been used with success in the treatment of ...
COYA 303 is an investigational biologic combination of COYA 301, Coya’s low-dose interleukin 2 (LD IL-2) and a GLP-1 receptor agonist (GLP-1RA), designed to deliver a multi-targeted immunomodulatory ...
A combination of two types of blood pressure-lowering drugs -- an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) ...
If your app requires the creation and manipulation of combinations of objects, the BigInteger structure in the Microsoft .NET Framework can offer huge advantages to combination functions. The ...
A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...
Erectile dysfunction associated with diabetes mellitus is caused in part by disordered endothelial smooth muscle relaxation, neuropathy, and a decrease in cavernosal nitric oxide synthase (NOS) ...
The aim of our study was to investigate antiproliferative effects of PEP005 in a panel of colon cancer cell lines that expressed various levels of PKCδ and to evaluate the effects of PEP005-based ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback